# Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma

> **NCT00525915** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 126 (actual)

## Conditions studied

- Esophageal Cancer
- Gastroesophageal Cancer

## Interventions

- **DRUG:** 5-Fluorouracil
- **DRUG:** Oxaliplatin
- **RADIATION:** Radiation Therapy
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT00525915
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2015-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00525915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00525915, "Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00525915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*